| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.3 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.3 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.3 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.031 | 0.3 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.051 | 0.3 |